GlaxoSmithKline LLC recalls
GlaxoSmithKline LLC is named on 2 recalls in Recall Relay's records since November 2023, from FDA; the most recent was May 17, 2024.
All 2, newest first.
-
Class IIIofficial
GlaxoSmithKline LLC recalls Tivicay PD (dolutegravir) 5mg Tablets for Oral SuspensionLabeling: Incorrect Lot and/or Expiration Date: The carton has incorrect expiration of 2026-MAY*, whereas the correct expiration date, which is on the tablet bottle label, is 2025-APR.
-
Class IIIofficial
GlaxoSmithKline LLC recalls ANORO ELLIPTA (umeclidinium and vilanterol inhalation powder) 62.5 mcg/25mcg. 1 inhaler contains 30 doses (60Failed Release Testing: Coarse Particle Mass for umeclidinium Out of Specification
This page groups recalls by the company name the agency printed, so it can include different companies with similar names, and a recall may name a store or distributor rather than the maker. It counts the recalls in Recall Relay's records, not a company's whole history; an FDA recall that lists several products counts once. Open a recall to see its details and the agency's official notice, which is always the final word. Recall Relay isn't affiliated with any agency or with the companies named here.
Severity labels say where they come from: “official” is the agency's own class, “advisory” is based on the agency's safety warning, and “est. risk” is Recall Relay's estimate from the hazard description, not an agency classification.
Hear about the next one
Recall Relay can email you when a new recall mentions GlaxoSmithKline LLC or any words you choose. Start with a free key (no card needed), then set up alerts on your account page.
Get recall alerts